Barclays analyst Charles Pitman CFA reiterated a Buy rating on UCB SA (0NZT – Research Report) today and set a price target of €240.00. The ...

Throughout the 1990s and early 2000s, UCB transformed from a hybrid pharma/chemical firm into a pure-play biopharmaceutical company by shedding its packaging, film, and chemical businesses.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does United Community Banks (UCB) have what it takes? Let's find out.

China's commitment to foster innovation and advance high-standard opening-up has provided global pharmaceutical companies ...

CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS. The Board of Directors invites the shareholders to the ordinary general meeting of the shareholders (the "General Meeting) ...

The bank published the auction notice on its website on Thursday (20 March), inviting potential buyers to submit price quotations by 24 April ...

UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...

United Community Banks (UCB) is headquartered in Greenville, and is in the Finance sector. The stock has seen a price change of -11.89% since the start of the year. The bank holding company is ...

Argenx is a hold due to limited catalysts in 2025, a rich valuation and clinical risk around label expansion. Read more about ...

UCB SA (OTCMKTS:UCBJF – Get Free Report)’s stock price passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $192.24 and traded as high as ...